Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice
Sarah J. Mitchell(Princeton University), Rafael de Cabo(National Institute on Aging), David W. Frederick(University of Pennsylvania), Sonia Cortassa(National Institute on Aging), Mark S. Schmidt(University of Iowa), Tyler B. Waltz(Medical College of Wisconsin), Tamzin Kaiser(National Institute on Aging), Ahmed Ali(National Institute on Aging), Miguel A. Aon(National Institute on Aging), David Sinclair(Center for Human Genetics), Evandro Fei Fang(National Institutes of Health), Hector H. Palacios(National Institute on Aging), Ignacio Navas‐Enamorado(National Institute on Aging), Michel Bernier(National Institutes of Health), Charles Brenner(City Of Hope National Medical Center), Anthony A. Sauve(Cornell University), Vilhelm A. Bohr(University of Copenhagen), Eun Young Kim(Chung-Ang University), Ning Zhang(Shanghai University), James L. Ellis(Tris Pharma (United States)), Andrea Di Francesco(Emcore (United States)), Peter J. Elliott(Advanced Process Combinatorics (United States)), Joseph A. Baur(University of Pennsylvania)
Cited by 332
Related Papers
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease
|Nature Neuroscience|2019|1.7k
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
|Cell Metabolism|2017|1k
The Ratio of Macronutrients, Not Caloric Intake, Dictates Cardiometabolic Health, Aging, and Longevity in Ad Libitum-Fed Mice
|Cell Metabolism|2014|922
Mitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms
|Trends in Neurosciences|2017|861